Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

10.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024).

Kidney international reports·2026
Same author

The Modified "ICTM" technique for total tongue reconstruction using profund artery perforator flap.

Plastic and reconstructive surgery·2026
Same author

[Effect of Biodegradable Mulching Film on Soil Microbial Community in Cotton Field was Revealed Based on Metagenomics].

Huan jing ke xue= Huanjing kexue·2026
Same author

Correlation analysis between sleep quality and depressive symptoms among rural elderly in China: An observational study.

World journal of psychiatry·2025
Same author

Earlier Hematuria Negative Conversion Was an Independent Predictor for Nephrotic Remission in Patients with Primary Membranous Nephropathy and Nephrotic Syndrome.

American journal of nephrology·2025
Same author

Healthcare cost of palliative care for patients with terminal illness: A meta-analysis.

International journal of nursing studies·2025

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.1K

Metabolomics in diabetes.

Ai-hua Zhang1, Shi Qiu1, Hong-ying Xu1

  • 1Key Laboratory of Chinmedomics and Metabolomics, Department of Pharmaceutical Analysis, National TCM Key Laboratory of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 11, 2013
PubMed
Summary
This summary is machine-generated.

Metabolomics reveals key insights into type 2 diabetes (T2D) mechanisms and identifies novel metabolite biomarkers for early detection and improved diagnostics. This approach aids in understanding T2D pathology and predicting disease onset.

Keywords:
BiomarkersDiabetesDiagnosisMetabolitesMetabolomics

More Related Videos

The MPLEx Protocol for Multi-omic Analyses of Soil Samples
10:12

The MPLEx Protocol for Multi-omic Analyses of Soil Samples

Published on: May 30, 2018

10.4K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.1K

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.1K
The MPLEx Protocol for Multi-omic Analyses of Soil Samples
10:12

The MPLEx Protocol for Multi-omic Analyses of Soil Samples

Published on: May 30, 2018

10.4K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.1K

Area of Science:

  • Biochemistry
  • Genomics
  • Metabolomics

Background:

  • Diabetes mellitus is a major global health concern, with type 2 diabetes (T2D) accounting for 90% of cases.
  • Early detection and intervention are crucial for managing T2D and preventing its complications.
  • Metabolomics offers powerful tools for understanding disease pathology and identifying biomarkers.

Purpose of the Study:

  • To review the application of metabolomics in understanding type 2 diabetes.
  • To highlight the discovery of metabolite-based biomarkers for T2D.
  • To elucidate the molecular mechanisms underlying T2D.

Main Methods:

  • Literature review focusing on metabolomics studies in T2D.
  • Analysis of small-molecule metabolite patterns associated with T2D phenotypes.
  • Exploration of metabolomics for biomarker discovery and diagnostic improvement.

Main Results:

  • Metabolomics provides novel insights into T2D pathogenesis.
  • Characteristic metabolite patterns can be identified to understand T2D.
  • Metabolite-based biomarkers show promise for early diagnosis and prediction of T2D.

Conclusions:

  • Metabolomics is instrumental in unraveling the complexities of T2D.
  • The identification of metabolite biomarkers through metabolomics can enhance diagnostic strategies.
  • Further research in metabolomics will advance T2D management and treatment.